Drugs / Glyceroltrinitrate
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 11 trial | ||||||
| Phase 1 | NCT00264186 | Jun 2005 → ? | — | Medical University of Vienna | Completed | No outcome recorded |
| Comparator or background therapy1 trial | ||||||
| — | NCT00226096 Background | Nov 2005 → Sep 2007 | intracerebral hemorrhage | The George Institute | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Glyceroltrinitrate | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00264186 ↗ |
| Known as | nitroglycerine | “Glyceroltrinitrate (nitroglycerine) 4, 8, 16 nmol/min over 3 min/dose level (two times; pre-dose and +3.5 hrs)” NCT00264186 ↗ |